CRDL
CRDL
NASDAQ · Pharmaceuticals

Cardiol Therapeutics Inc-A

$1.06
+0.00 (+0.00%)
As of Jun 21, 10:37 PM ET ·
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +2,190.6% upside
Low Target $16.80
Average Target $24.28
High Target $33.59
Current Price $1.06
Current
$1.06
Target
$24.28
$16.80 $24.28 avg $33.59
Scenario Analysis
Bear Case
$16.80
1,484.9%
Low target
Base Case
$24.28
+2,190.6%
Avg target
Bull Case
$33.59
+3,068.9%
High target
Risk/Reward
2.1x
Favorable
Price in Context
52-Week High
$2.33
-54.5% from high
52-Week Low
$1.23
+-13.5% from low
Target vs 52W High
$24.28
+942.1% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 39 79% $1,330.33 +19.1%
RDY
Dr. Reddy's Laboratories
Sell 44 50% +0.0%
JNJ
Johnson & Johnson
Buy 31 68% $299.55 +24.3%
MRK
Merck & Co. Inc.
Buy 36 69% $159.27 +32.1%
PFE
Pfizer Inc.
Hold 36 42% $33.90 +41.0%
BMY
Bristol-Myers Squibb Co
Hold 36 39% $174.50 +217.3%
ZTS
Zoetis Inc
Buy 24 58% $209.87 +168.5%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -33.2%